ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $254 | -99.9% | 11,751 | -0.1% | 0.00% | – |
| Q3 2022 | $228,000 | -58.5% | 11,764 | -57.5% | 0.00% | -100.0% |
| Q2 2022 | $550,000 | -36.9% | 27,702 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $871,000 | +219.0% | 29,191 | +148.6% | 0.00% | – |
| Q4 2021 | $273,000 | -25.6% | 11,740 | -0.3% | 0.00% | – |
| Q3 2021 | $367,000 | -31.1% | 11,775 | -22.2% | 0.00% | -100.0% |
| Q2 2021 | $533,000 | +0.8% | 15,137 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $529,000 | +3.7% | 15,000 | +10.3% | 0.00% | 0.0% |
| Q4 2020 | $510,000 | +12.3% | 13,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $454,000 | +26.1% | 13,600 | 0.0% | 0.00% | – |
| Q2 2020 | $360,000 | +115.6% | 13,600 | +33.3% | 0.00% | – |
| Q1 2020 | $167,000 | -35.5% | 10,200 | 0.0% | 0.00% | – |
| Q4 2019 | $259,000 | +27.0% | 10,200 | 0.0% | 0.00% | – |
| Q3 2019 | $204,000 | -38.0% | 10,200 | 0.0% | 0.00% | – |
| Q2 2019 | $329,000 | 0.0% | 10,200 | 0.0% | 0.00% | – |
| Q1 2019 | $329,000 | +31.6% | 10,200 | 0.0% | 0.00% | – |
| Q4 2018 | $250,000 | -25.6% | 10,200 | 0.0% | 0.00% | – |
| Q3 2018 | $336,000 | -7.2% | 10,200 | 0.0% | 0.00% | – |
| Q2 2018 | $362,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |